Search research articles
Contact Us
Filters
Showing results (21-30 of 261) with videos related to
Page
of 27
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism
|
December 2, 2008
Molecular pathology of thyroid cancer: diagnostic and clinical implications
James A Fagin, Nicholas Mitsiades
Nature Reviews. Endocrinology
|
December 11, 2019
Therapeutic breakthroughs for metastatic thyroid cancer
Vera Tiedje, James A Fagin
Endocrinology
|
February 1, 1987
Relative increase in insulin-like growth factor I messenger ribonucleic acid levels in compensatory renal hypertrophy
J A Fagin, S Melmed
Bailliere'S Clinical Endocrinology and Metabolism
|
April 1, 1995
Molecular pathogenesis of pituitary tumours
V Herman-Bonert, J A Fagin
The Journal of Clinical Investigation
|
September 28, 2020
Oncogene-induced DNA damage: cyclic AMP steps into the ring
James A Fagin, John H Petrini
Trends in Cardiovascular Medicine
|
January 18, 2011
Growth factors, cytokines, and vascular injury
J A Fagin, J S Forrester
Current Opinion in Cell Biology
|
February 24, 2009
Role of MAPK pathway oncoproteins in thyroid cancer pathogenesis and as drug targets
Jeffrey A Knauf, James A Fagin
The New England Journal of Medicine
|
December 14, 2016
Biologic and Clinical Perspectives on Thyroid Cancer
James A Fagin, Samuel A Wells
The New England Journal of Medicine
|
September 15, 2016
Biologic and Clinical Perspectives on Thyroid Cancer
James A Fagin, Samuel A Wells
Thyroid : Official Journal of the American Thyroid Association
|
September 5, 2023
Progress in Thyroid Cancer Genomics: A 40-Year Journey
James A Fagin, Yuri E Nikiforov
Page
of 27
Search research articles
Search
Showing results (21-30 of 261) with videos related to
Sort By:
Page
of 27
Best Practice & Research. Clinical Endocrinology & Metabolism
|
December 2, 2008
Molecular pathology of thyroid cancer: diagnostic and clinical implications
James A Fagin, Nicholas Mitsiades
Nature Reviews. Endocrinology
|
December 11, 2019
Therapeutic breakthroughs for metastatic thyroid cancer
Vera Tiedje, James A Fagin
Endocrinology
|
February 1, 1987
Relative increase in insulin-like growth factor I messenger ribonucleic acid levels in compensatory renal hypertrophy
J A Fagin, S Melmed
Bailliere'S Clinical Endocrinology and Metabolism
|
April 1, 1995
Molecular pathogenesis of pituitary tumours
V Herman-Bonert, J A Fagin
The Journal of Clinical Investigation
|
September 28, 2020
Oncogene-induced DNA damage: cyclic AMP steps into the ring
James A Fagin, John H Petrini
Trends in Cardiovascular Medicine
|
January 18, 2011
Growth factors, cytokines, and vascular injury
J A Fagin, J S Forrester
Current Opinion in Cell Biology
|
February 24, 2009
Role of MAPK pathway oncoproteins in thyroid cancer pathogenesis and as drug targets
Jeffrey A Knauf, James A Fagin
The New England Journal of Medicine
|
December 14, 2016
Biologic and Clinical Perspectives on Thyroid Cancer
James A Fagin, Samuel A Wells
The New England Journal of Medicine
|
September 15, 2016
Biologic and Clinical Perspectives on Thyroid Cancer
James A Fagin, Samuel A Wells
Thyroid : Official Journal of the American Thyroid Association
|
September 5, 2023
Progress in Thyroid Cancer Genomics: A 40-Year Journey
James A Fagin, Yuri E Nikiforov
Page
of 27